The Molecular Pathology of Non-Malignant Haematological Disease
-
By
-
A. D. Blann
-
R. G. Dunn
-
May 22, 2026
By
A. D. Blann
R. G. Dunn
May 22, 2026
by A. D. Blann, R. G. Dunn
May 22, 2026
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
April 13, 2026
Consensus guideline outlines screening, diagnosis, and follow-up strategies for long-term impairments after intensive care unit discharge.
April 13, 2026